|
|
|
Living patients: blood (10 mL in fluoride tube), urine, hair, faeces, gastric
contents as appropriate. Post mortem: as for living patients plus appropriate tissue esp liver, muscle, brain, fat. Other materials: as appropriate. |
|
Drugs and organic chemicals - immunoassay, spectrophotometry, TLC, GC, HPLC.
GCMS is usually required for confirmation. Metals and some non-metals - atomic absorption spectrophotometry. |
| Upper therapeutic level, mg/L | Toxic threshold mg/L | |
| Anti-depressants | ||
| Amitriptyline* | 0.25 | 0.5 |
| Dothiepin* | 0.2 | 0.5 |
| Doxepin* | 0.25 | 0.5 |
| Fluoxetine | 0.5 | Not known |
| Imipramine* | 0.3 | 0.5 |
| Mobenclamide | 10 | 30 |
| Analgesics | ||
| Morphine (total) | 0.1 | 0.2 |
| Codeine (total) | 0.4 | 0.6 |
| Pethidine | 2.0 | 2.0 |
| Propoxyphene* | 1.0 | 1.0 |
| Anti-psychotics | ||
| Thioridazine* | 1.5 | 1.5 |
| Chlorpromazine* | 2.0 | 2.0 |
| Haloperidol | 0.05 | 0.1 |
| Benzodiazepines | ||
| Diazepam | 2.0 | 2.0 |
| Oxazepam | 2.0 | 2.0 |
| Temazepam | 2.0 | 2.0 |
| Nitrazepam | 0.2 | 0.2 |
| Flunitrazepam | 0.05 | 0.05 |
|
|